ArticleOncotarget2016

Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model.

Takashi Murakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.